1. Home
  2. KFRC vs BWAY Comparison

KFRC vs BWAY Comparison

Compare KFRC & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kforce Inc.

KFRC

Kforce Inc.

HOLD

Current Price

$26.15

Market Cap

499.7M

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$13.50

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFRC
BWAY
Founded
1962
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
499.7M
450.8M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
KFRC
BWAY
Price
$26.15
$13.50
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$38.50
$13.25
AVG Volume (30 Days)
271.6K
133.2K
Earning Date
04-27-2026
03-11-2026
Dividend Yield
6.19%
N/A
EPS Growth
N/A
N/A
EPS
1.96
N/A
Revenue
$1,329,007,000.00
N/A
Revenue This Year
$2.78
$301.23
Revenue Next Year
$4.32
$24.33
P/E Ratio
$13.21
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$24.49
$7.84
52 Week High
$50.14
$26.63

Technical Indicators

Market Signals
Indicator
KFRC
BWAY
Relative Strength Index (RSI) 37.98 30.06
Support Level $25.01 $11.55
Resistance Level $28.41 $16.14
Average True Range (ATR) 1.13 0.90
MACD 0.16 -0.21
Stochastic Oscillator 30.15 13.99

Price Performance

Historical Comparison
KFRC
BWAY

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance, accounting, and other professional staffing services. The company operates two business segments: the Technology segment, which provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. The FA segment offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting, business and cost analysis; and taxation and treasury. The majority of revenue is earned through the Technology segment.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: